Related Experiment Video
Updated: Jun 9, 2026
10:09
Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
Published on: January 7, 2019
KLF6 regulates osteoclastogenesis through DUSP16 in OVX-induced bone loss
Chen Yang1,2, Wei Zhang1, Xin Liu1
1Department of Orthopedics, The First Affiliated Hospital of Soochow University, Suzhou, 215006, China.
Science China. Life Sciences
|June 8, 2026
Summary
Krüppel-like factor 6 (KLF6) suppresses osteoclast differentiation, a key process in postmenopausal osteoporosis. Overexpressing KLF6 in mice reduced bone loss, indicating its therapeutic potential.
Area of Science:
- Bone Biology
- Endocrinology
- Molecular Biology
Background:
- Estrogen deficiency accelerates bone resorption by osteoclasts, contributing to postmenopausal osteoporosis.
- Osteoclast differentiation is a critical process regulated by various molecular factors.
Purpose of the Study:
- To investigate the role of Krüppel-like factor 6 (KLF6) in osteoclast differentiation.
- To evaluate KLF6's potential in mitigating bone loss in an ovariectomized (OVX) mouse model.
Main Methods:
- Analyzed KLF6 expression during osteoclast differentiation in vitro and in OVX mice.
- Utilized RNA sequencing and Chromatin Immunoprecipitation (ChIP) analysis.
- Employed adeno-associated virus (AAV) for in vivo KLF6 overexpression in OVX mice.
Main Results:
- KLF6 expression decreased during osteoclast differentiation, with a more pronounced reduction in OVX models.
- Reduced KLF6 expression promoted osteoclast differentiation.
- KLF6 inhibited the MAPK signaling pathway by upregulating DUSP16, suppressing osteoclast differentiation.
- KLF6 overexpression in vivo reduced OVX-induced bone loss.
Conclusions:
- KLF6 plays an inhibitory role in osteoclast differentiation, partly through the DUSP16-mediated regulation of the MAPK pathway.
- KLF6 represents a potential therapeutic target for treating bone loss associated with estrogen deficiency and osteoporosis.
Related Concept Videos
01:31Osteoclasts in Bone Remodeling
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
01:40Bone Remodeling
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
01:25Role of Vitamins in Maintaining Bone Health
The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
01:17Hormones and Bone Tissue
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
01:21Skeleton and Calcium Homeostasis
Calcium is not only the most abundant mineral in bone but also the most abundant mineral in the human body. Calcium ions are needed for bone mineralization, tooth health, heart rate regulation and strength of contraction, blood coagulation, the contraction of smooth and skeletal muscle cells, and the regulation of nerve impulse conduction. The average calcium level in the blood is about 10 mg/dL. When the body cannot maintain this level, a person will experience hypo or hypercalcemia.
01:29Bone Disorders
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...